|
|
| RLN811b | 肺癌及肺组织组合芯片，附病理分级，TNM和临床分期（根据AJCC第八版分期），80例/80点，替代LC811a | | 点 数 | 80 | 例 数 | 80 | | 行 数 | 8 | 列 数 | 10 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Malignant (IA3) Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (IIIA) Malignant (IIIB) Normal (*) |
|
|
TISSUE ARRAYS RLN811b |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
A | | | | | | | | | | | |
B | | | | | | | | | | | |
C | | | | | | | | | | | |
D | | | | | | | | | | | |
E | | | | | | | | | | | |
F | | | | | | | | | | | |
G | | | | | | | | | | | |
H | | | | | | | | | | | |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 48 | M | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIB | Malignant | N |
| A2 | 2 | 54 | F | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIB | Malignant | N |
| A3 | 3 | 50 | F | Lung | Mucinous adenocarcinoma | 1 | T3N0M0 | IIB | Malignant | N |
| A4 | 4 | 70 | M | Lung | Adenocarcinoma | 2 | T1cN0M0 | IA3 | Malignant | N |
| A5 | 5 | 65 | F | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIB | Malignant | N |
| A6 | 6 | 55 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| A7 | 7 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| A8 | 8 | 77 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| A9 | 9 | 62 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| A10 | 10 | 71 | F | Lung | Adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant | N |
| B1 | 11 | 35 | F | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIB | Malignant | N |
| B2 | 12 | 59 | M | Lung | Adenocarcinoma | 2 | T1cN3M0 | IIIB | Malignant | N |
| B3 | 13 | 43 | F | Lung | Adenocarcinoma | 2 | T2aN2M0 | IIIA | Malignant | N |
| B4 | 14 | 58 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| B5 | 15 | 43 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| B6 | 16 | 49 | F | Lung | Adenocarcinoma | 2 | T1bN1M0 | IIB | Malignant | N |
| B7 | 17 | 75 | M | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| B8 | 18 | 65 | M | Lung | Solid adenocarcinoma | 3 | T2bN2M0 | IIA | Malignant | N |
| B9 | 19 | 53 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| B10 | 20 | 67 | M | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| C1 | 21 | 57 | M | Lung | Adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| C2 | 22 | 82 | M | Lung | Adenocarcinoma | 3 | T2aN1M0 | IIB | Malignant | N |
| C3 | 23 | 52 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| C4 | 24 | 60 | F | Lung | Invasive adenocarcinoma | * | T2aN0M0 | IB | Malignant | N |
| C5 | 25 | 54 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| C6 | 26 | 47 | M | Lung | Invasive adenocarcinoma | * | T2N0M0 | IB | Malignant | N |
| C7 | 27 | 57 | F | Lung | Papillary adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| C8 | 28 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C9 | 29 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| C10 | 30 | 67 | M | Lung | Lepidic predominant adenocarcinoma | * | T2N0M0 | IB | Malignant | N |
| D1 | 31 | 50 | F | Lung | Lepidic predominant adenocarcinoma | * | T3N0M0 | IIB | Malignant | N |
| D2 | 32 | 48 | F | Lung | Lepidic predominant adenocarcinoma | * | T2N0M0 | IB | Malignant | N |
| D3 | 33 | 67 | M | Lung | Lepidic predominant adenocarcinoma | * | T2N1M0 | IIB | Malignant | N |
| D4 | 34 | 75 | F | Lung | Lepidic predominant adenocarcinoma | * | T2N1M0 | IIB | Malignant | N |
| D5 | 35 | 68 | M | Lung | Squamous cell carcinoma | 1 | T4N0M0 | IIIA | Malignant | N |
| D6 | 36 | 68 | M | Lung | Squamous cell carcinoma | 1 | T3N0M0 | IIB | Malignant | N |
| D7 | 37 | 67 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| D8 | 38 | 74 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| D9 | 39 | 56 | M | Lung | Squamous cell carcinoma | 2 | T3N2M0 | IIIB | Malignant | N |
| D10 | 40 | 65 | M | Lung | Squamous cell carcinoma | 2 | T2bN0M0 | IIA | Malignant | N |
| E1 | 41 | 69 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| E2 | 42 | 51 | F | Lung | Squamous cell carcinoma | 3 | T2bN1M0 | IIB | Malignant | N |
| E3 | 43 | 48 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| E4 | 44 | 62 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| E5 | 45 | 66 | M | Lung | Squamous cell carcinoma (tumor necrosis) | * | T3N1M0 | IIIA | Malignant | N |
| E6 | 46 | 54 | M | Lung | Squamous cell carcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| E7 | 47 | 64 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| E8 | 48 | 43 | F | Lung | Small cell carcinoma | * | T2bN0M0 | IIA | Malignant | N |
| E9 | 49 | 52 | F | Lung | Small cell carcinoma | * | T2bN1M0 | IIB | Malignant | N |
| E10 | 50 | 61 | M | Lung | Small cell carcinoma | * | T4N1M0 | IIIA | Malignant | N |
| F1 | 51 | 44 | F | Lung | Small cell carcinoma | * | T2aN0M0 | IB | Malignant | N |
| F2 | 52 | 61 | M | Lung | Small cell carcinoma | * | T2aN0M0 | IB | Malignant | N |
| F3 | 53 | 31 | F | Lung | Small cell carcinoma | * | T2bN0M0 | IIA | Malignant | N |
| F4 | 54 | 51 | M | Lung | Small cell carcinoma | * | T4N1M0 | IIIA | Malignant | N |
| F5 | 55 | 53 | M | Lung | Small cell carcinoma | * | T2bN0M0 | IIA | Malignant | N |
| F6 | 56 | 37 | F | Lung | Small cell carcinoma | * | T2bN0M0 | IIA | Malignant | N |
| F7 | 57 | 53 | F | Lung | Small cell carcinoma | * | T1cN2M0 | IIIA | Malignant | N |
| F8 | 58 | 64 | M | Lung | Small cell carcinoma | * | T3N1M0 | IIIA | Malignant | N |
| F9 | 59 | 60 | M | Lung | Small cell carcinoma | * | T2bN1M0 | IIB | Malignant | N |
| F10 | 60 | 33 | M | Lung | Small cell carcinoma | * | T2bN2M0 | IIIA | Malignant | N |
| G1 | 61 | 55 | M | Lung | Small cell carcinoma | * | T4N1M0 | IIIA | Malignant | N |
| G2 | 62 | 36 | M | Lung | Small cell carcinoma | * | T2aN2M0 | IIIA | Malignant | N |
| G3 | 63 | 47 | M | Lung | Small cell carcinoma | * | T2aN1M0 | IIB | Malignant | N |
| G4 | 64 | 51 | F | Lung | Small cell carcinoma | * | T2aN1M0 | IIB | Malignant | N |
| G5 | 65 | 47 | F | Lung | Small cell carcinoma | * | T3N0M0 | IIB | Malignant | N |
| G6 | 66 | 56 | M | Lung | Small cell carcinoma | * | T3N1M0 | IIIA | Malignant | N |
| G7 | 67 | 41 | M | Lung | Small cell carcinoma | * | T4N2M0 | IIIB | Malignant | N |
| G8 | 68 | 49 | M | Lung | Small cell carcinoma | * | T2aN0M0 | IIB | Malignant | N |
| G9 | 69 | 60 | M | Lung | Small cell carcinoma | * | T2aN0M0 | IIB | Malignant | N |
| G10 | 70 | 36 | M | Lung | Small cell carcinoma | * | T2bN1M0 | IIB | Malignant | N |
| H1 | 71 | 40 | F | Lung | Lung tissue | * | * | * | Normal | N |
| H2 | 72 | 23 | M | Lung | Lung tissue | * | * | * | Normal | N |
| H3 | 73 | 33 | M | Lung | Lung tissue | * | * | * | Normal | N |
| H4 | 74 | 30 | M | Lung | Lung tissue | * | * | * | Normal | N |
| H5 | 75 | 16 | F | Lung | Lung tissue | * | * | * | Normal | N |
| H6 | 76 | 30 | M | Lung | Lung tissue | * | * | * | Normal | N |
| H7 | 77 | 21 | F | Lung | Lung tissue | * | * | * | Normal | N |
| H8 | 78 | 2 | F | Lung | Lung tissue | * | * | * | Normal | N |
| H9 | 79 | 24 | M | Lung | Lung tissue | * | * | * | Normal | N |
| H10 | 80 | 48 | M | Lung | Lung tissue | * | * | * | Normal | N | | Tissue Marker |
|
